Cafepharma Today

March 5 2025 - Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Jazz hands over $935M to buy Chimerix for near-approval cancer drug
Kenvue settles proxy fight with activist Starboard, appoints three directors
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
DOGE claims $30M savings from canceling 30 FDA leases
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Imperatives of Healthcare Reform
Seeking Alpha
Wednesday, May 27, 2009 - 7:36am
tags:
healthcare reform, AstraZeneca, Eli Lilly, JNJ, Pfizer, Merck
Johnson & Johnson says FDA wants 3 more months for review of psoriasis injection Stelara
Yahoo/AP
Wednesday, May 27, 2009 - 7:33am
tags:
JNJ, psoriasis, Stelara
Proxy update: Biovail settles, Biogen fights
Fierce Pharma
Tuesday, May 26, 2009 - 10:13pm
tags:
proxies, Biovail, Biogen Idec
Talecris Likely Target for New Entrant into Plasma Therapeutics
Gerson Lehrman Group
Tuesday, May 26, 2009 - 10:12pm
tags:
Talecris, Plasma Therapeutics, CSL
US high court to decide on allowing Vioxx suits
Yahoo/AP
Tuesday, May 26, 2009 - 10:10pm
tags:
Merck, Vioxx, painkillers, lawsuits
Drug CEOs Switch Tactics on Reform
WSJ Online
Tuesday, May 26, 2009 - 10:08pm
tags:
Pharma CEOs, healthcare reform
AstraZeneca wins judgment in Seroquel lawsuit
Yahoo/AP
Tuesday, May 26, 2009 - 10:07pm
tags:
AstraZeneca, Seroquel
Hemispherx waiting a bit longer for FDAs Ampligen decision
Bizjournals.com
Tuesday, May 26, 2009 - 9:20pm
tags:
FDA, Hemispherx, Ampligen
GSK and Pfizer's HIV Joint Venture: Why It’s a Path Forward
InVivo
Tuesday, May 26, 2009 - 9:14pm
tags:
GSK, Pfizer, HIV, partnerships
Merck says WHO pre-qualifies vaccine Gardasil
Yahoo/AP
Tuesday, May 26, 2009 - 9:13pm
tags:
Merck, WHO, vaccines, cervical cancer, Gardasil
Bristol-Myers cancer drug gets full approval
Yahoo/AP
Tuesday, May 26, 2009 - 9:12pm
tags:
Bristol-Myers Squibb, Sprycel, leukemia
FDA wants more data, but no new trials, before approving Botox for upper limb spasticity
Yahoo/AP
Tuesday, May 26, 2009 - 9:10pm
tags:
FDA, Botox, Allergan
Alkermes Outlook Remains Bleak
Yahoo/Zacks.com
Tuesday, May 26, 2009 - 11:05am
tags:
Alkermes
Court to consider whether to allow Vioxx lawsuits
Yahoo/AP
Tuesday, May 26, 2009 - 11:04am
tags:
Vioxx, Merck
Astellas launches eczema drug for new indication
Trading Markets
Tuesday, May 26, 2009 - 9:50am
tags:
Astellas, eczema, Protopic
Simcere Pharmaceutical buys stake in vaccine maker
Yahoo/AP
Tuesday, May 26, 2009 - 9:49am
tags:
Simcere, vaccines
[video]Mad About Options: Baxter International Flashback
Yahoo/TheStreet.com
Tuesday, May 26, 2009 - 9:47am
tags:
options, Baxter International
Spectrum Pharmaceuticals wins $4.3 million in arbitration award from Cell Therapeutics
Yahoo/AP
Tuesday, May 26, 2009 - 9:46am
tags:
Spectrum Pharmaceuticals, Cell Therapeutics, Zevalin
MAP's Migraine Drug Provides Big Pain Relief
TheStreet.com
Tuesday, May 26, 2009 - 9:44am
tags:
MAP Pharmaceuticals, migraines, Levadex
Biogen says 2 proxy advisory firms support its slate
Yahoo/Reuters
Tuesday, May 26, 2009 - 9:11am
tags:
Biogen Idec

Pages

Latest CP Wire Articles

FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Latest Pharmagather Articles

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws
Drug Channels
The Continuing Crisis, Part VI: Rare Diseases at the FDA and More
In the Pipeline
PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)
Drug Channels
Progress on RNA-Based Cancer Vaccines
In the Pipeline
Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
The Thiazide Target, At Last
In the Pipeline
Drug Channels News Roundup, February 2025: Part D vs. Pharmacies, Accumulator Madness, Wholesaler Vertical Integration, IRA vs. MDs, and a 340B Cartoon
Drug Channels
Neurodegeneration Might Come Down to RNA
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information